GRANULES vs THEMISMED: Stock Comparison

Granules India Limited vs Themis Medicare Limited

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Granules India Limited is the larger company by market capitalisation. Granules India Limited shows a lower P/E, a higher ROE and faster revenue growth, while Themis Medicare Limited shows a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Granules India Limited and Themis Medicare Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, GRANULES is more favourable on 10 of 13 scored metrics and THEMISMED on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
GRANULES is the larger company
₹20,94,875.17 L Cr vs ₹972 Cr
P/E Ratio
GRANULES has a lower P/E
31.63x vs 883.33x
P/B Ratio
THEMISMED has a lower P/B
2.45x vs 4.16x
EPS
GRANULES has higher earnings per share
₹26.97 vs ₹0.12
Dividend Yield
THEMISMED has a higher dividend yield
0.43% vs 0.21%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 6.7%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 0%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
22.8% vs 6.74%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESTHEMISMED
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESTHEMISMED
Live Price₹845.4₹105.78
Day Change0.31%-1.99%
Volume7.05 L34,271
52-Week High₹910₹148
52-Week Low₹432.6₹64.95
Distance from 52W High-7.1%-28.53%

Valuation

MetricGRANULESTHEMISMED
Market Cap₹20,94,875.17 L Cr₹972 Cr
P/E Ratio31.63x883.33x
P/B Ratio4.16x2.45x
EPS₹26.97₹0.12
Book Value₹205.21₹43.06
Dividend Yield0.21%0.43%

Growth

MetricGRANULESTHEMISMED
Revenue Growth (TTM YoY)22.8%6.7%
EPS Growth (TTM YoY)31.3%0%
Qtr Sales Growth22.8%6.74%
Qtr Profit Growth44.6%192%

Profitability & Leverage

MetricGRANULESTHEMISMED
ROE13.7%0.29%
ROCE15.5%2.74%
Net Margin11.15%0.33%
Operating Margin22.1%-2.9%
Debt to Equity0.3x25.11x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESTHEMISMED
Promoter Holding37.67%57.5%
FII Holding17.5% 2.19 pp0.01% 0.1 pp
DII Holding16.11% 0.9 pp0.01%
Public Holding28.38% 1.28 pp32.87% 0.09 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Granules India Limited and Themis Medicare Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.